by Gemma Escarré,
RheoDx, a CataloniaBio & HealthTech member, has opened a round of investment to raise €350,000 on the Capital Cell crowdfunding platform. The funds will go to finish technical development of a portable medical device that improves monitoring of patients with haematological diseases (anaemia, liquid cancer, clotting disorders, etc.).
This medical device can detect anomalies in blood cells immediately and affordably, from just one drop of blood. It is a patented technology that came out of research led by professor Aurora Hernández-Machado with Centre de Recerca Matemàtica.
RheoDx was created in 2018 by Oliver Balcells, CEO; Samantha López, CSO; and Joan Grasas, CPO. It is promoted by the Mobile World Capital Barcelona Foundation.
We recommend this video of CataloniaBio & HealthTech interviewing the founding team: